Dividend compounder review

TLX

Telix Pharmaceuticals Limited · NASDAQ · US

Healthcare · Biotechnology

Chart Factor Intelligence Back to Screener
Score23.50/100
Confidence68.00/100
DecisionInsufficient Data
RatingAvoid
Scoring

Quality breakdown

Dividend Reliability 0.0 / 25 Payment history, cuts, growth, and regularity.
Dividend Sustainability 8.5 / 20 Payout, free cash flow, dividend cover, and debt.
Business Quality 11.5 / 25 Scale, cash generation, growth, margins, and returns.
Valuation Discipline 3.5 / 15 Yield, P/E, and price stretch versus long-term trend.
Long-Term Trend 0.0 / 15 Trend line, long return history, and drawdown control.
Metrics

Dividend and business context

Dividend Years0
Dividend Yield0.00%
Payout Ratio0.0%
Dividend Cut 5YNo
Net Income$-7.1M
Free Cash Flow$-61.1M
FCF Covers DividendUnknown
Debt / Equity1.12
P/E80.4
Revenue Growth 5Y197.0%
Net Margin-0.9%
ROE-1.9%
Price vs Trend8.4%
3Y Return-35.6%
5Y Return-
CurrencyUSD
Warnings

Review flags

No usable dividend history found.
Free cash flow is negative.
Less than five years of weekly price history available.
Dividend diary

Activity record

TLX dividend review warning Warning · Warning

Less than five years of weekly price history available.